US House of Representatives Science Committee beats FDA, EPA, NSF, and DOE for slow work

On Thursday last week, we testified in a hearing before the U.S. House of Representatives’ Committee on Science, giving an update on government action to address nanotech environmental, health, and safety (EHS) risks. If attendance is anything to go by, interest in this issue has grown since the Sci...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

EPA move to strengthen clean emissions regulations is more symbolic than impactful

News Commentary | February 02, 2022

The U.S. Environmental Protection Agency (EPA)'s proposed rule to reinstate the limit on mercury emissions for coal‑fired plants reverses a Trump administration decision to not enforce it. But most utilities have already complied with the rule, which was first enforced more than 10 years ago, by ... Not part of subscription

What we are doing isn't working: IPCC states window for climate change action is narrowing

News Commentary | March 10, 2022

The Intergovernmental Panel on Climate Change (IPCC)'s most recent report released evidence that past and current global efforts to reduce emissions and mitigate climate change have not made an impact. In fact, the report states that climate change risks and vulnerabilities are much more severe than... Not part of subscription

European Commission proposes blanket ban on over 12,000 chemicals of concern by 2030

News Commentary | May 04, 2022

The European Commission released a "Restriction Roadmap," a political commitment to ban most toxic chemicals, as part of the zero‑pollution goal in the EU Green Deal. Specifically, the ban aims to outlaw all flame retardants, bisphenols, per‑ and polyfluoroalkyl substances (PFAS), and all polyvinyl ... Not part of subscription